CORNERSTONE PHARMACEUTICALS INC

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• JBJonathan BlumDirector
• ADAaron DrillickDirector
• SFSim FassDirector
• BGBernard GrossDirector
• HJHoward JonasDirector
• DPDavid PolinskyDirector · Executive Officer
• HPH. PolinskyDirector
• HPHerman PolinskyDirector
• SPStuart PolinskyDirector
• DPDavid Polinsky, Esq.Director
• HPH. Gilbert Polinsky, Esq.Executive Officer
• RRRobert RodriguezDirector · Executive Officer
• RSRobert ShorrDirector · Executive Officer
• RSRobert Shorr, Ph. D., D.I.C.Director · Executive Officer
• ASA. SternDirector
• JSJoseph SternDirector
• CSClifford StraubExecutive Officer
• CSClifford Straub, JrExecutive Officer
• CSClifford Straub Jr., CPAExecutive Officer
• PWPatrick WilmerdingDirector

• 19 Dec 2024Therapeutic methods and compositions for treating cancer using devimistat and a fatty acid oxidation inhibitor, a tyrosine kinase inhibitor, a glutaminase inhibitor, and/or a glycolysis inhibitorapplication
• 18 Jan 2024Therapeutic Methods And Compositions For Treating Pancreatic Cancer Using Devimistatapplication
• 12 Dec 2017Methods Of Treating Pancreatic And Ovarian Cancers Using Compositions Containing An Ion Pair Of A Lipoic Acid Derivativegranted
• 26 Apr 2016Methods Of Treating Colon, Lung, And Liver Cancers Using Compositions Containing An Ion Pair Of A Lipoic Acid Derivativegranted
• 12 Nov 2015Pharmaceutical Compoundsapplication
• 06 Oct 2015Lipoic Acid Derivativesgranted
• —Therapeutic Methods And Compositions For Treating Pancreatic Cancer Using Devimistatapplication
• —Therapeutic Methods And Compositions For Treating Sarcoma Using Devimistatapplication
• —Therapeutic Methods And Compositions For Treating Cancer Using Devimistat And A Fatty Acid Oxidation Inhibitor, A Tyrosine Kinase Inhibitor, A Glutaminase Inhibitor, And/or A Glycolysis Inhibitorapplication
• —Conjugates Of A Lipoic Acid Derivative And Anti-proliferation Agent And Medical Uses Thereofapplication
• —Combination Therapy Compositions And Methods Using Lipoic Acid Derivatives And An Anti-proliferation Agentapplication
• —Pharmaceutical Formulations Containing Lipoic Acid Derivativesapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.